Filing Details
- Accession Number:
- 0001104659-22-088034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-09 17:22:00
- Reporting Period:
- 2022-08-08
- Accepted Time:
- 2022-08-09 17:22:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1739426 | Rvl Pharmaceuticals Plc | RVLP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283061 | A Brian Markison | C/O Rvl Pharmaceuticals Plc 400 Crossing Boulevard Bridgewater NJ 08807 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-08-08 | 850,000 | $1.55 | 2,976,020 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
